• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Can delayed/extended-release methylphenidate allow for once daily evening dosing in ADHD?

Bioengineer by Bioengineer
April 2, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Mary Ann Liebert, Inc., publishers

New Rochelle, NY, April 2, 2019–A new three-part study showed that a delayed-release, extended-release form of methylphenidate could be given to adults in the evening with or without food and would not exert any clinically meaningful effect for at least 10 hours after administration. These positive findings suggest that HLD200 could provide a novel and more flexible alternative to treating attention deficit hyperactivity disorder (ADHD) in children compared to the currently used immediate-release methylphenidate. The design of each study and the intriguing results are reported in the Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. Click here
) to read the full-text article free on the Journal of Child and Adolescent Psychopharmacology website.

The article is entitled “Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate: Evaluation of Dose Proportionality, Food Effect, Multiple-Dose Modeling, and Comparative Bioavailability with Immediate-Release Methylphenidate in Healthy Adults.” Coauthors Bev Incledon, PhD, Ironshore Pharmaceuticals & Development, Inc., (Grand Cayman, Cayman Islands) and colleagues from University of Maryland School of Pharmacy (Baltimore, MD) and Highland Therapeutics, Inc. (Toronto, Canada) set up a series of studies to be able to evaluate different doses of HLD200, the potential impact of taking the drug in a fasted state or following a high-fat evening meal, and the effects, if any, of a low-fat versus a medium-fat breakfast. The authors also evaluated different dosing strategies.

“For many parents whose children with ADHD are very restless and impulsive from the moment they awake, mornings are very difficult before their first dose of medicine starts to work. This new formulation may potentially correct these early morning problems,” says Harold S. Koplewicz, MD, Editor-in-Chief of the Journal of Child and Adolescent Psychopharmacology and President of the Child Mind Institute in New York.

###

About the Journal

Journal of Child and Adolescent Psychopharmacology is an authoritative peer-reviewed journal published bimonthly in print and online. The Journal is dedicated to child and adolescent psychiatry and behavioral pediatrics, covering clinical and biological aspects of child and adolescent psychopharmacology and developmental neurobiology. Complete tables of content and a sample issue may be viewed on the Journal of Child and Adolescent Psychopharmacology website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Cyberpsychology, Behavior, and Social Networking, Games for Health Journal, and Violence and Gender. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Media Contact
Kathryn Ryan
kryan@liebertpub.com

Original Source

https://home.liebertpub.com/news/can-delayed-extended-release-methylphenidate-allow-for-once-daily-evening-dosing-in-adhd/3532

Related Journal Article

http://dx.doi.org/10.1089/cap.2018.0122

Tags: BehaviorClinical TrialsMedicine/HealthSocial/Behavioral Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Virtual Planning and Patient-Specific Plates Achieve Mandibular Reconstruction in Feasibility Study

Virtual Planning and Patient-Specific Plates Achieve Mandibular Reconstruction in Feasibility Study

November 18, 2026
Absence of ECG Monitoring Delays Initial Epinephrine in Hospital Cardiac Arrest

Absence of ECG Monitoring Delays Initial Epinephrine in Hospital Cardiac Arrest

November 18, 2026

Bone-Modifying Agent Reports Reveal Broad Time-to-Onset Window for Jaw Osteonecrosis

November 18, 2026

Date Seed Oil Modulates Microgravity-Induced Mitochondrial and Inflammatory Dysfunction in Organoids

November 18, 2026
Please login to join discussion

POPULAR NEWS

  • Review Identifies Stage-Specific Biological Bottlenecks Limiting Long-Term Cancer Metastasis Control

    Review Identifies Stage-Specific Biological Bottlenecks Limiting Long-Term Cancer Metastasis Control

    29 shares
    Share 12 Tweet 7
  • Lightweight AI Models Enable Reliable Slip Detection on Microcontroller Hardware

    29 shares
    Share 12 Tweet 7
  • Overharvesting Threatens Traditional Cosmetic Plants in South Africa’s Eastern Cape

    29 shares
    Share 12 Tweet 7
  • Distributed Latent Encoding Cuts Cloud Media Retrieval Latency Across Six Datasets

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Virtual Planning and Patient-Specific Plates Achieve Mandibular Reconstruction in Feasibility Study

Engineered Streptomyces Host Boosts Antitumor Antibiotic Tsukubarubicin Yield Thirty-Nine-Fold

Humus Composition Governs Essential Nutrient Availability Across Kazakhstan’s Calcic Agricultural Soils

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.